BDKRB2 and brain neoplasm: Of note, in animal models, B2R agonist like Cereport® (RMP-7) has been used by the intracarotid route in order to increase the BBB permeability and consequently enhance the delivery of chemotherapeutic agents to the brain tumor area [45], [46], [47].